Search results for "C25"

showing 10 items of 566 documents

Early rehabilitation of cancer patients - a randomized controlled intervention study.

2013

Published version of an article in the journal: BMC Cancer. Also available from the publisher at: http://dx.doi.org/10.1186/1471-2407-13-9 Open access Background: Faced with a life-threatening illness, such as cancer, many patients develop stress symptoms, i.e. avoidance behaviour, intrusive thoughts and worry. Stress management interventions have proven to be effective; however, they are mostly performed in group settings and it is commonly breast cancer patients who are studied. We hereby present the design of a randomized controlled trial (RCT) evaluating the effectiveness and cost-effectiveness of an individual stress-management intervention with a stepped-care approach in several cance…

Research designCounselingMaleCancer ResearchMedicin och hälsovetenskapTime Factorsmedicine.medical_treatmentCost-Benefit AnalysisAnxietyVDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Onkologi: 762Medical and Health Scienceslaw.inventionStress Disorders Post-TraumaticStudy ProtocolRandomized controlled trialCost of IllnesslawNeoplasmsSurveys and QuestionnairesActivities of Daily LivingAdaptation PsychologicalLongitudinal StudiesProspective StudiesHospital CostsIndividual stress managementProspective cohort studyFatiguemedia_commonDepressionAdjuvant/curative therapyVDP::Medical disciplines: 700::Health sciences: 800lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensMental HealthTreatment OutcomeOncologyResearch DesignVDP::Midical sciences: 700::Clinical medical sciences: 750::Oncology: 762FemaleWorryMental Health ServicesSleep Wake Disordersmedicine.medical_specialtyImpact of event scalePsychometricsmedia_common.quotation_subjectMotor Activitylcsh:RC254-282Breast cancerIntervention (counseling)GeneticsmedicineHumansRCT with stepped-care approachMotivationCognitive Behavioral Therapybusiness.industryPhysical activityCancermedicine.diseasePhysical therapyCognitive therapyQuality of LifebusinessSleepStress PsychologicalBMC cancer
researchProduct

Missing Evidences in Cancer Genetics: The Retinoblastoma Paradigm

2008

BACKGROUND: Retinoblastoma (Rb) is the most common primary malignant intraocular tumour in childhood. The "two hit" theory, formulated by Knudson in 1971 to explain the variegated clinical expression of the disease, led to the discovery of the so called tumour suppressor genes and the identification of the Rb1 as the prototype of such genes. Mutations of the Rb1 gene are now commonly believed to be the "cause" retinoblastoma, although epidemiological, clinical, and biological evidences argue against it. MATERIAL/METHODS: The Authors have performed a systematic review of available data concerning clinical and diagnostic aspects of retinoblastoma, including molecular genetics. Meta analysis o…

Retinoblastoma pRBCancer Researchlcsh:CytologyRetinoblastomaCell BiologyGeneral Medicinelcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282Retinoblastoma ProteinPathology and Forensic MedicineMutationHumansMolecular MedicineGenetic Predisposition to Diseaselcsh:QH573-671Letter to the EditorCellular Oncology : the Official Journal of the International Society for Cellular Oncology
researchProduct

Morbidity and mortality after esophagectomy for esophageal carcinoma: A risk analysis

2005

Abstract Background The study was aimed to identify pre- and intraoperative risk factors that potentially influence morbidity and mortality after esophagectomy for esophageal carcinoma with particular emphasis on the predominant tumor types. Patients and methods Between September 1985 and March 2004, 424 patients underwent esophagectomy for esophageal carcinoma. Of these, 186 (43.9%) patients had a transhiatal, and 231 (54.5%) patients underwent a transthoracic procedure with two-field lymphadenectomy. Pre-, intraoperative risk factors and tumor characteristics were included in the risk analysis to assess their influence on postoperative morbidity and mortality. Results Multivariate analysi…

Risk analysismedicine.medical_specialtybusiness.industryMortality ratemedicine.medical_treatmentResearchlcsh:Surgerylcsh:RD1-811medicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282SurgeryOncologyRisk analysis (engineering)EsophagectomyIntensive caremedicineCarcinomaAdenocarcinomaSurgeryLymphadenectomyRisk factorbusinessWorld Journal of Surgical Oncology
researchProduct

Energetic aspects of intramolecular coupling between the nucleotide binding site and the distal switch II region of the yeast RAS2 protein

1994

AbstractWe have studied the interaction of the yeast RAS2 protein with guanine nucleotides using energetic parameters for the dissociation of RAS·nucleotide complexes. The results indicated that a Gly → Ser substitution at position 82 led to an altered interaction with GppNHp and, to a lesser extent, also with GDP. It was also possible to conclude that structural perturbation of Gly82 can stimulate nucleotide release by decreasing the energetic barrier for nucleotide dissociation. This, together with the observation that residues 80 and 81 are involved in the response of RAS to nucleotide exchange factors without affecting GDP binding per se, suggests a potential mechanism for exchange fact…

Saccharomyces cerevisiae ProteinsStereochemistryCdc25GuanineSaccharomyces cerevisiaeGlycineBiophysicsSaccharomyces cerevisiaeGuanosine DiphosphateBiochemistryFungal ProteinsStructure-Activity RelationshipSCD25chemistry.chemical_compoundGTP-Binding ProteinsStructural BiologyEscherichia coliSerineGeneticsNucleotideBinding siteRas2Molecular Biologychemistry.chemical_classificationGuanylyl ImidodiphosphateBinding SitesCDC25biologyGDP bindingTemperatureCell Biologybiology.organism_classificationGuanine NucleotidesRecombinant ProteinsYeastchemistryras ProteinsGDP exchange factorbiology.proteinThermodynamicsRASFEBS Letters
researchProduct

Gradient Estimate for Solutions to Poisson Equations in Metric Measure Spaces

2011

Let $(X,d)$ be a complete, pathwise connected metric measure space with locally Ahlfors $Q$-regular measure $\mu$, where $Q>1$. Suppose that $(X,d,\mu)$ supports a (local) $(1,2)$-Poincar\'e inequality and a suitable curvature lower bound. For the Poisson equation $\Delta u=f$ on $(X,d,\mu)$, Moser-Trudinger and Sobolev inequalities are established for the gradient of $u$. The local H\"older continuity with optimal exponent of solutions is obtained.

Sobolev inequalityMathematics::Analysis of PDEsHölder conditionPoincaré inequality31C25 31C45 35B33 35B65Poisson equationSpace (mathematics)01 natural sciencesMeasure (mathematics)Sobolev inequalitysymbols.namesakeMathematics - Analysis of PDEs0103 physical sciencesFOS: Mathematics0101 mathematicsMathematicsMoser–Trudinger inequalityCurvatureRegular measureta111010102 general mathematicsMathematical analysisPoincaré inequalityMetric (mathematics)Riesz potentialsymbols010307 mathematical physicsPoisson's equationAnalysisAnalysis of PDEs (math.AP)
researchProduct

Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma

2021

Simple Summary Neuroblastoma (NB) is the most common extra-cranial solid paediatric cancer and is responsible for 15% of childhood cancer deaths. Patients with NB are characterized by presenting a very heterogeneous clinic (inter-tumoural heterogeneity) and also both spatial and temporal intra-tumour heterogeneity (ITH) reflected in their genetic aberrations, which may be the consequence of the coexistence of different microenvironments within the tumour. Applying pangenomic techniques to detect genomic aberrations in different biopsies (solid and liquid) of high risk NB (HR-NB) we have detected spatial ITH in a surprisingly high percentage (almost 40%) of the studied cohort. Moreover, a po…

Solid tumourCancer Research<i>MYCN</i> amplificationGenetic heterogeneityMYCN amplificationNeoplasms. Tumors. Oncology. Including cancer and carcinogensGenomicsctDNABiologySNPaArticleOncologyMycn amplificationGenomic ProfileCancer researchgenomicssegmental chromosomal aberrationHigh risk neuroblastomaLiquid biopsytumour microenvironmentSurvival rateRC254-282Cancers
researchProduct

Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis

2020

Background: An optimal sequential systemic therapy for advanced hepatocellular carcinoma (HCC) has not been discovered. We developed a decision model based on available clinical trials to identify an optimal risk/benefit strategy for sequences of novel systemic agents. Methods: A Markov model was built to simulate overall survival (OS) among patients with advanced HCC. Three first-line (single-agent Sorafenib or Lenvatinib, and combination of Atezolizumab plus Bevacizumab) followed by five second-line treatments (Regorafenib, Cabozantinib, Ramucirumab, Nivolumab, Pembrolizumab) were compared in fifteen sequential strategies. The likelihood of transition between states (initial treatment, ca…

SorafenibOncologyCancer Researchmedicine.medical_specialtySurvivalBevacizumabHepatocellular carcinomaSequential therapylcsh:RC254-282ArticleSettore MED/01 - Statistica MedicaRamucirumab03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSettore BIO/13 - Biologia ApplicataAtezolizumabInternal medicineRegorafenibmedicineSettore SECS-S/05 - Statistica SocialeSettore MED/12 - GastroenterologiaSystemic therapybusiness.industrylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensTumor progressionClinical trialOncologychemistry030220 oncology & carcinogenesis030211 gastroenterology & hepatologyNivolumabLenvatinibbusinessmedicine.drugCancers
researchProduct

Dans quelle mesure les préférences individuelles contraignent-elles le développement du marché de l'assurance dépendance ?

2015

Dans un contexte de vieillissement de la population, différents scenarii sont envisagés pour réformer l’organisation et le financement de la prise en charge des personnes âgées dépendantes. La place de la prévoyance individuelle dans le financement de la dépendance est à ce titre largement débattue. À l’heure actuelle, malgré des restes à charge potentiellement conséquents, peu d’individus disposent d’une couverture assurantielle. Cet article vise à enrichir la littérature existante en évaluant dans quelle mesure les préférences observées dans la population limitent cette couverture. Nous mobilisons pour cela l’enquête Patrimoine et préférences vis-à-vis du temps et du risque (Pater) de 201…

Statistics and ProbabilityEconomics and Econometricsdemande d’assurance[SHS.STAT]Humanities and Social Sciences/Methods and statistics050208 financeSociology and Political Science05 social sciencespréférence pour le présentPréférences individuelles[SHS.ECO]Humanities and Social Sciences/Economics and Financeperte d’autonomieassurance dépendanceassurance0502 economics and business[SHS.STAT] Humanities and Social Sciences/Methods and statistics[ SHS.ECO ] Humanities and Social Sciences/Economies and financesaversion du risque.dépendance050207 economics[SHS.ECO] Humanities and Social Sciences/Economics and Finance[ SHS.STAT ] Humanities and Social Sciences/Methods and statisticsdépendance ; perte d’autonomie ; assurance dépendance ; demande d’assurance ; préférence pour le présent ; aversion du risque ; Codes JEL C25- D91- G22- I12- I18- J14ComputingMilieux_MISCELLANEOUSprise en charge
researchProduct

Impact of the Hypoechogenicity Criteria on Thyroid Nodule Malignancy Risk Stratification Performance by Different TIRADS Systems

2021

Background: Various Thyroid Imaging and Reporting data systems (TIRADS) are used worldwide for risk stratification of thyroid nodules. Their sensitivity is high, while the specificity is suboptimal. The aim of the study was to compare several TIRADS systems and evaluate the effect of hypoechogenicity as a sign of risk of malignancy on the overall assessment of diagnostic accuracy. Methods: The prospective study includes 274 patients with 289 thyroid nodules to whom US and risk of malignancy were assessed according to four TIRADS systems—European (EU-TIRADS), Korean (K-TIRADS), TIRADS by American College of Radiology (ACR TIRADS), and modified Kwak et al. TIRADS (L-TIRADS) systems, in which …

Thyroid nodulesCancer Researchmedicine.medical_specialtyBethesda systemMalignancyArticleBiopsymedicinefine-needle aspiration biopsyRC254-282medicine.diagnostic_testbusiness.industryultrasoundTIRADSThyroidEchogenicityNeoplasms. Tumors. Oncology. Including cancer and carcinogensNodule (medicine)medicine.diseasemedicine.anatomical_structureFine-needle aspirationOncologythyroid noduleRadiologymedicine.symptombusinessCancers
researchProduct

Performance of Contrast-Enhanced Ultrasound in Thyroid Nodules: Review of Current State and Future Perspectives

2021

Simple Summary Ultrasound has been used as baseline imaging for thyroid nodules for decades; nevertheless, no single feature is sensitive or specific enough to exclude or confirm thyroid malignancy. Therefore, clinical practice and research still focus on less invasive diagnostic patterns to reduce unnecessary fine-needle aspiration biopsies or surgery. The main advantage of CEUS is the ability to assess the sequence and intensity of vascular perfusion and hemodynamics in the thyroid nodule, thus providing real-time characterization of nodule features, and considered a valuable new approach in the determination of benign vs. malignant nodules. In addition, contrast agents used in CEUS can h…

Thyroid nodulesCancer Researchmedicine.medical_specialtycontrast-enhanced ultrasound (CEUS)ReviewMalignancyPapillary thyroid cancermedicinethyroid cancerpapillary thyroid cancerFollicular thyroid cancerThyroid cancerRC254-282business.industrythyroid nodulesfollicular thyroid cancerThyroidNeoplasms. Tumors. Oncology. Including cancer and carcinogensNodule (medicine)medicine.diseasemedicine.anatomical_structureOncologycontrast-enhanced ultrasound (CEUS); follicular thyroid cancer; papillary thyroid cancer; thyroid cancer; thyroid nodulesRadiologymedicine.symptombusinessContrast-enhanced ultrasoundCancers
researchProduct